Antiva Biosciences, a spinout of UC San Diego, closed a $22M Series C financing in March. Antiva is a clinical stage biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by Human Papilloma Virus (HPV) infection. Osage University Partners, a venture capital firm partnered with UC San Diego that invests exclusively in startups that are commercializing university research, invested in this round.
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego mined the FDA Adverse Effect Reporting System (FAERS) database for depression symptoms in patients taking ketamine for pain. They found that depression was reported half as often among the more than 41,000 patients who took ketamine, as compared to patients who took any other drug or drug combination for pain.
The next installment of the UC San Diego series, Evening with an Entrepreneur, will feature scientist, inventor, serial entrepreneur, innovator, and long-time UC San Diego supporter, Dr. Tina Nova. Nova will sit down with Biocom’s Joe Panetta for an interview to discuss her unique entrepreneurial background and success in molecular diagnostics.
UC San Diego announced its first eight proof-of-concept awards to advance university inventions to commercial impact. Funded through the new “Accelerating Innovations to Market (AIM)” program, these milestone-driven projects are designed to de-risk early-stage technologies.
A new study suggests that more small-scale fishing boats are operating in the Gulf of California than is economically and ecologically sustainable, suggesting that local fishermen are spending more time and money to catch fewer fish.
UC San Diego’s Office of Innovation and Commercialization (OIC) launched the Entrepreneurs-in-Residence (EIR) program in 2015 to accelerate the creation of new startup companies. The OIC, a Research Affairs unit, will honor the newly appointed 2017 EIR cohort and thank the 2016 cohort for their hard work with a reception, Apr. 17, at Bella Vista Social Club and Caffé in the Sanford Consortium.